{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-013078","form_type":"8-K","ticker":"SBC","cik":"0001930313","company_name":"SBC Medical Group Holdings Inc","filed_at":"2026-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.787369+00:00","generated_at":"2026-05-15T08:42:39.405544+00:00","sec_items":["2.02","7.01","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"medium","headline":"SBC Medical Q4 2025 net income up 117% to $14M; EPS $0.14, revenue $40M (-11% YoY)","bullets":["Net income attributable to SBC Medical Group was $14M, up 117% YoY; EPS $0.14, up 133% YoY.","Total revenues $40M, down 11% YoY; EBITDA $14M, down 35% YoY; EBITDA margin 34% vs 46% prior year.","Franchise locations increased 34 to 283; customer count in LTM 6.6M, up 12% YoY; repeat rate 72%.","Return on equity improved to 23%, up 9.8 percentage points YoY."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-013078","json":"https://secwatch.observer/filing/0001493152-26-013078.json","markdown":"https://secwatch.observer/filing/0001493152-26-013078.md","text":"https://secwatch.observer/filing/0001493152-26-013078.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1930313/000149315226013078/0001493152-26-013078-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1930313/000149315226013078/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:42:39.405544+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cedeb837d274633889e62e7630ed4d523ddf7379","claim":"SBC Medical Group Holdings Inc reported fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve mont results: revenue Total revenues were $40 million, net income Net Income attributable to SBC Medical Group was $14 million, EPS earnings per share ... was $0.14.","evidence_excerpt":"year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve months ended December 31, 2025) Fourth Quarter 2025 Highlights ● Total revenues were $40 million, representing an 11% year-over-year decrease. ● Net Income attributable to SBC Medical Group was $14 million, representing a 117% year-over-year increase. ● Earnings per share","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1930313/000149315226013078/0001493152-26-013078-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fourth quarter of fiscal year 2025 (three months ended December 31, 2025) and for the full fiscal year 2025 (twelve mont"},{"label":"Revenue","value":"Total revenues were $40 million"},{"label":"Net income","value":"Net Income attributable to SBC Medical Group was $14 million"},{"label":"EPS","value":"earnings per share ... was $0.14"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}